Summary. Eight patients suffering from primary hyperparathyroidism were studied in basal conditions, i. e. during a saline infusion and under somatostatin administration (a 250 fL9 bolus injection followed by continuous infusion of 500 fL9 per hour over 240 min). Introduction.
Summary. Eight patients suffering from primary hyperparathyroidism were studied in basal conditions, i. e. during a saline infusion and under somatostatin administration (a 250 fL9 bolus injection followed by continuous infusion of 500 fL9 per hour over 240 min). The (Fiske and Subbarow, 1925) .
Plasma immunoreactive levels of parathormone (iPTH) were determined by an heterogeneous immunological system : labelled porcine PTH and antiporcine PTH antibodies supplied by C. Arnaud (Gueris, 1974 (fig. 1) . Therefore, fractional absorption at the completion of the absorption process, i. e. at the sixth hour (FA Ca), was not statistically different whether the patients were infused with somatostatin or saline (table 1).
As shown on table 1, the somatostatin infusion resulted in slower intestinal transit time. The time of peak absorption was significantly delayed and the mean transit time was longer than under saline.
As indicated on figure 2, plasma concentrations of calcium, phosphorus and 25-OH-D remained unchanged during the entire period of somatostatin infusion. In two patients whose plasma samples were assayed for iPTH, there was no significant change in that parameter after somatostatin infusion. ' Discussion.
The present results show that cyclic somatostatin infused intravenously reduces the intestinal calcium absorption. However, as in other studies (Evensen, Hanssen and Berstad, 1978 ; Scholz and Schwille, 1978) , the absorption rate was only depressed during the first 2 hours. This effect could be due either to unspecific actions or to a direct inhibition of the active calcium transport across the intestinal barrier (Holdsworth, 1975) , the latter being mainly regulated by the active metabolites of vitamin D derived from the sequential hydroxylation of vitamin D, by the liver (Blunt, De Luca and Schnoes, 1968) and the kidney (Norman, 1974) . Renal hydroxylation which results in the production of the 1,25 (OH) 2 vitamin D 3 is also controlled by calcium (Bikle and Rasmussen, 1975) , phosphorus (Gray et at., 1977) and PTH (De Luca, 1978 (Metz et al., 1978) . It 
